About Essenlix
Essenlix is a company based in Monmouth Junction (United States) founded in 2013. It operates as a HealthTech, and Direct-to-Consumer (D2C). Essenlix has raised $20 million across 1 funding round from investors including Carret Private and Quadrant. Essenlix offers products and services including iMOST-L, Q-Card, and iMOST Dock. Essenlix operates in a competitive market with competitors including Withings, Ultrahuman, Oura, iHealth Labs and Masimo, among others.
- Headquarter Monmouth Junction, United States
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Essenlix Corporation
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$20 M (USD)
in 1 rounds
-
Latest Funding Round
$20 M (USD), Series A
Aug 09, 2018
-
Investors
Carret Private
& 1 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Essenlix
Essenlix offers a comprehensive portfolio of products and services, including iMOST-L, Q-Card, and iMOST Dock. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Automated device for HGB, WBC, and 5-DIFF analysis.
Single-use biochip with reagents for iMOST analyzer.
Supportive dock for iMOST platform testing operations.
Unlock access to complete
Unlock access to complete
Funding Insights of Essenlix
Essenlix has successfully raised a total of $20M through 1 strategic funding round. The most recent funding activity was a Series A round of $20 million completed in August 2018. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 1
- Last Round Series A — $20.0M
-
First Round
First Round
(09 Aug 2018)
- Investors Count 2
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Aug, 2018 | Amount | Series A - Essenlix | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Essenlix
Essenlix has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include Carret Private and Quadrant. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Quadrant Management is engaged in private equity investments.
|
Founded Year | Domain | Location | |
|
Multi-family office services are provided to high net worth families.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Essenlix
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Essenlix
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Essenlix Comparisons
Competitors of Essenlix
Essenlix operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Withings, Ultrahuman, Oura, iHealth Labs and Masimo, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Connected devices for health, sleep, and activity monitoring are developed.
|
|
| domain | founded_year | HQ Location |
Metabolic health is tracked via devices and fitness platforms.
|
|
| domain | founded_year | HQ Location |
Health-tracking smart rings and biosensors are developed for biometric monitoring.
|
|
| domain | founded_year | HQ Location |
Personal healthcare devices for vital monitoring are designed and produced.
|
|
| domain | founded_year | HQ Location |
Provider of wide range of devices to monitor health parameters
|
|
| domain | founded_year | HQ Location |
Wearable devices for metabolic health insights are provided.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Essenlix
Frequently Asked Questions about Essenlix
When was Essenlix founded?
Essenlix was founded in 2013 and raised its 1st funding round 5 years after it was founded.
Where is Essenlix located?
Essenlix is headquartered in Monmouth Junction, United States. It is registered at Monmouth Junction, New Jersey, United States.
Is Essenlix a funded company?
Essenlix is a funded company, having raised a total of $20M across 1 funding round to date. The company's 1st funding round was a Series A of $20M, raised on Aug 09, 2018.
What does Essenlix do?
Essenlix is engaged in transforming health diagnostics through its innovative iMOST platform. The company operates in the healthcare sector, specializing in medical devices for personal and clinical use. Solutions are developed using nanotechnology, advanced imaging, and artificial intelligence to enable instant mobile self-testing. Tests for various biomarkers in body fluids like blood and saliva are provided, delivering lab-quality results quickly. The platform is designed to be user-friendly, cost-effective, and accessible, supporting digital health monitoring worldwide.
Who are the top competitors of Essenlix?
Essenlix's top competitors include Withings, Ultrahuman and Oura.
What products or services does Essenlix offer?
Essenlix offers iMOST-L, Q-Card, and iMOST Dock.
Who are Essenlix's investors?
Essenlix has 2 investors. Key investors include Carret Private, and Quadrant.